SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 77 filers reported holding SESEN BIO INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $41,382 | +42.7% | 67,895 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -48.2% | 67,895 | 0.0% | 0.00% | – |
| Q2 2022 | $56,000 | -82.0% | 67,895 | -86.8% | 0.00% | – |
| Q1 2022 | $311,000 | -26.1% | 515,680 | 0.0% | 0.00% | – |
| Q4 2021 | $421,000 | +9.1% | 515,680 | +6.2% | 0.00% | – |
| Q3 2021 | $386,000 | -80.6% | 485,545 | +12.8% | 0.00% | -100.0% |
| Q2 2021 | $1,989,000 | +1253.1% | 430,374 | +663.7% | 0.00% | – |
| Q1 2021 | $147,000 | +90.9% | 56,356 | 0.0% | 0.00% | – |
| Q4 2020 | $77,000 | +381.2% | 56,356 | +412.3% | 0.00% | – |
| Q3 2020 | $16,000 | +100.0% | 11,000 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | +14.3% | 11,000 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -41.7% | 11,000 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | -7.7% | 11,000 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | -23.5% | 11,000 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -66.0% | 11,000 | -77.3% | 0.00% | – |
| Q1 2019 | $50,000 | – | 48,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
| Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
| Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
| MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
| Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |